BioSpace News Archive

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that Iain Stuart, Ph.D., Chief Scientific Officer of VYNE, will be presenting at the B&T Cell-Mediated Autoimmune Disease Drug Development Conference (in-person) on July 27, 2022.

Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in the “Muscle Beach” panel for the 2022 Wedbush PacGrow Healthcare Conference, being held virtually on August 9, 2022, at 2:20 pm ET.

Frontera Therapeutics, a clinical-stage biotechnology company that seeks to develop novel and best-in-class gene therapy medicines to improve the lives of patients across multiple disease areas, today announced successful completion of a $160 million Series B funding round.

Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a biopharmaceutical company deploying its novel oral biologic platform to discover, develop and commercialize first-in-class, oral enzyme therapeutics for difficult-to treat metabolic diseases, today reported completion of enrollment of the first two cohorts of its ALLN-346 Phase 2a Study 202 in gout patients with stage 2 (cohort A) and stage 3 (cohort B) chronic kidney disease (CKD).

Wilmington, Delaware, United States, Transparency Market Research Inc.: The clinical risk grouping solutions market is anticipated to observe steady growth during the forecast period of 2021-2031.

According to Transparency Market Research’s latest report on the global diabetes devices market for the historical period 2017–2018 and forecast period 2019–2027, increase in prevalence of diabetes, and increase in adoption of insulin pumps among type 1 diabetes patients are projected to drive the global diabetes devices market during the forecast period.

One of the key growth promoting factors for this market is daily stress of life and that keeps on increasing.

According to Transparency Market Research’s latest report on the global veterinary endoscopes market for the historical period 2017–2018 and forecast period 2019–2027, rapid rise in pet population worldwide is projected to drive the global veterinary endoscopes market during the forecast period.

The global surgical sutures market is primarily driven by increased prevalence’s of chronic diseases. The suture is a tool used in stitching cutaneous wounds and to close surgical opening.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Stocking Refurbished Medical Inventories Prepares Hospitals to Tackle COVID-19 Pandemic Coronavirus has exposed the vulnerability of healthcare systems worldwide.